UDK: 615.03:616.379-008.64
A. V. Sabanov, I. N. Barykina
Кафедра терапии и эндокринологии ФУВ ВолгГМУ
Modern drugs for the treatment of type 2 diabetes have different molecular targets and different mechanism of actions.Administration of these drugs as monotherapy and combination therapy allows a reliable control of di sease. However a rational choice of strategy of pharmacotherapy of type 2 diabetes is a difficult problem in clinical practice. In the article some aspects of this problem are considered.
type 2 diabetes, glycemic control, the choice of strategy of pharmacotherapy.
Сабанов Алексей Валерьевич – д. м. н., профессор кафедры терапии и эндокринологии ФУВ ВолгГМУ, e-mail: family1@yandex.ru.